NASDAQ: RCKT
Rocket Pharmaceuticals Inc Stock Ownership - Who owns Rocket Pharmaceuticals?

Insider buying vs selling

Have Rocket Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Elisabeth BjorkDirector2025-08-2710,000$3.41
$34.10kBuy
Martin WilsonGeneral Counsel2025-08-19588$3.00
$1.76kSell
John MilitelloVice President of Finance Treasurer Principal Accounting Officer2025-08-19361$3.00
$1.08kSell
Jonathan David SchwartzChief Medical Gene Therapy Officer2025-08-19805$3.00
$2.41kSell
Jonathan David SchwartzChief Medical Gene Therapy Officer2025-08-181,680$3.07
$5.15kSell
John MilitelloVice President of Finance Treasurer Principal Accounting Officer2025-08-18699$3.07
$2.14kSell
Gaurav ShahCEO2025-08-182,234$3.05
$6.81kSell
Martin WilsonGeneral Counsel2025-08-181,004$3.07
$3.08kSell
Jonathan David SchwartzChief Medical Gene Therapy Officer2025-08-1411,161$3.02
$33.70kSell
John MilitelloVice President of Finance Treasurer Principal Accounting Officer2025-08-147,043$3.02
$21.26kSell

1 of 4

RCKT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RCKT insiders and whales buy or sell their stock.

RCKT Shareholders

What type of owners hold Rocket Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Roderick Wong31.98%34,508,759$113.19MInsider
Rtw Investments LP31.16%33,617,724$110.27MInsider
Rtw Investments LP16.39%17,687,772$58.02MInstitution
Maverick Capital Ltd7.75%8,363,813$27.43MInstitution
Blackrock Inc6.88%7,428,676$24.37MInstitution
Vanguard Group Inc5.67%6,122,461$20.08MInstitution
Suvretta Capital Management LLC3.84%4,143,333$13.59MInstitution
Mpm Bioimpact LLC3.62%3,903,081$12.80MInstitution
Devon Park Associates LP3.02%3,253,566$10.67MInsider
Devang Kantesaria3.01%3,243,709$10.64MInsider

1 of 3

RCKT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RCKT50.44%49.56%Net SellingNet Selling
ABSI59.87%33.21%Net SellingNet Buying
ADCT60.72%38.28%Net BuyingNet Selling
ABEO45.20%54.80%Net SellingNet Selling
FULC62.17%37.83%Net Selling

Rocket Pharmaceuticals Stock Ownership FAQ

Who owns Rocket Pharmaceuticals?

Rocket Pharmaceuticals (NASDAQ: RCKT) is owned by 88.02% institutional shareholders, 86.47% Rocket Pharmaceuticals insiders, and 0.00% retail investors. Roderick Wong is the largest individual Rocket Pharmaceuticals shareholder, owning 34.51M shares representing 31.98% of the company. Roderick Wong's Rocket Pharmaceuticals shares are currently valued at $111.81M.

If you're new to stock investing, here's how to buy Rocket Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.